The BIOMAP project has successfully concluded.

Read this article to learn more about the impact of BIOMAP and view our results in the publication section.

Stay tuned for more results to come. We will continue to update the publication section and inform you via our LinkedIn account when new results are published.

Novartis Pharma AG

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines in cancer, cardio-vascular, renal and metabolism, immunology and dermatology, ophthalmology, neuroscience and respiratory, gene and cell therapies, and cost-saving generic pharmaceuticals. Novartis Group companies employ appr. 108,000 associates (2020) and operate in more than 140 countries around the world.

Role within BIOMAP

With its strong scientific and clinical expertise in immune-dermatology, Novartis supports the BIOMAP teams with data, bioinformatic analysis resources and expert knowledge to better understand these inflammatory skin diseases. By closely collaborating with academic and industrial BIOMAP members, Novartis fosters the scientific exchange to advance the scientific culture and future collaborations.

Main Contacts

Photo of Dr Frank Kolbinger
Dr Frank Kolbinger
Photo of Sandro Bruno
Sandro Bruno